Savior Lifetec Corporation

4167

TW0004167002

Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 23:00:00 12/05/2024 BST			5-day change	1st Jan Change
22.85 ^TWD	+4.34%		+10.12%	+1.78%

03-18	Savior Lifetec Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Savior Lifetec Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Savior Lifetec Corporation Announces Appointment of Cheng, Chin-Hwa as Member of the Audit Committee

June 01, 2022 at 10:52 am

Savior Lifetec Corporation announced changes in the members of the audit committee with appointment of Cheng, Chin-Hwa as new member . Date of change is June 1 2022. Resume of the new position holder: Independent director of Chongdah health co.

Ltd.

Latest news about Savior Lifetec Corporation

Savior Lifetec Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-18	CI
Savior Lifetec Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Pengrui Construction Co. Ltd announced that it expects to receive TWD 240 million in funding from Savior Lifetec Corporation	23/08/23	CI
Savior Lifetec Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/08/23	CI
Savior Lifetec Corporation Announces Executive Changes	04/08/23	CI
Savior Lifetec Corporation Announces Dividend Distribution, Payable August 04, 2023	19/06/23	CI
Savior Lifetec Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Savior Lifetec Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/11/22	CI
Savior Lifetec Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	05/08/22	CI
Savior Lifetec Corporation Appoints as Xu Fang Zhen Head of Internal Audit	05/08/22	CI
Savior Lifetec Corporation and Shenzhen China Resources Gosun Pharmaceutical Co.,Ltd Signs Exclusive Sales Contract for Ertapenem in the Mainland Market	08/06/22	CI
Savior Lifetec Corporation Announces Appointment of Cheng, Chin-Hwa as Member of the Audit Committee	01/06/22	CI
Savior Lifetec Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	04/05/22	CI
Savior Lifetec Corporation Approves the Appointment of Cheng, Chin-Hwa as Members of the Compensation Committee	15/04/22	CI
Savior Lifetec Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	11/03/22	CI
Savior Lifetec Corporation Announces Demise of Chung, Ping-Hong, Member of Audit Committee and Compensation Committee	11/03/22	CI
EPISTAR Corporation signed a contract to acquire Plant of Savior Lifetec Corporation in Zhunan Science Park from Savior Lifetec Corporation for TWD 610 million.	02/03/22	CI
Savior Lifetec Corporation Announces Change the Representative of Its Legal Person Director, Effective on February 1, 2022	28/01/22	CI
Savior Lifetec Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	03/11/21	CI
Savior Lifetec Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	05/08/21	CI
Savior Lifetec Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	18/03/21	CI
Savior Lifetec Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	04/11/20	CI
Savior Lifetec Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2020	12/08/20	CI
Savior Lifetec Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020	03/05/20	CI
Savior Lifetec Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	16/03/20	CI

Chart Savior Lifetec Corporation

Duration

Period

More charts

Company Profile

SAVIOR LIFETEC CORPORATION is a Taiwan-based company principally engaged in the development, manufacture and distribution of antibiotic bulk pharmaceutical chemicals and intermediates. The Companyâs products portfolio mainly consists of Meropenem and Imipenem/Cilastatin, Meropenem as well as Ertapenem, among others, which are used as spectrum antibiotics. In addition, it is involved in the provision of APIs intermediates as well as bio-pharmaceutical technology services. The Company distributes its products to Europe, the Americas, Asia and other markets.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SAVIOR LIFETEC CORPORATION	+1.78%	214M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.09%	43.27B
OTSUKA HOLDINGS CO., LTD.	+25.28%	22.92B
SANDOZ GROUP AG	+19.22%	15.43B
CIPLA LIMITED	+13.51%	12.95B
ZYDUS LIFESCIENCES LIMITED	+44.01%	11.83B
ONO PHARMACEUTICAL CO., LTD.	-7.79%	6.91B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.26%	5.55B